With the goal of solving these problems, Tensive created the project REGENERA to develop a cell-free porous scaffold made of resorbable biomaterials with a biomimetic architecture which aims to promote blood vessels and soft tissue recruitment. It is designed to be gradually replaced by the patients’ soft tissue, allowing to restore a natural aspect and feeling of the reconstructed breast. The technology has not yet been tested in humans.

REGENERA project has been funded by the European Union's Horizon 2020 research and innovation programme, under grant agreement No 812002, for a total budget of €2.69 million. The goal of the project is to complete the development of a breakthrough solution for breast reconstruction, in particular for post-lumpectomy patients, for whom there are no definitive, optimal reconstructive options available.

ISO 13485 certification

ISO 13485 certification

10/26/2021 - Tensive announces the obtainment of the ISO 13485 certification for: Design, development and manufacturing of sterile and implantable scaffolds for soft and connective tissues treatment.